Prognostic Value of CD133 and SOX2 in Advanced Cancer

BACKGROUND: The prognostic value of CD133 and SOX2 expression in advanced cancer remains unclear. This study was first conducted to investigate the association between CD133 or SOX2 positivity and clinical outcomes for advanced cancer patients. METHODS: Hazard ratios (HRs) with 95% confidence interv...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Susu, Huang, Tao, Wu, Xing, Wang, Xiyu, Liu, Shanshan, Yang, Wei, Shi, Qi, Li, Hongjia, Hou, Fenggang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332999/
https://www.ncbi.nlm.nih.gov/pubmed/30693028
http://dx.doi.org/10.1155/2019/3905817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332999/
https://www.ncbi.nlm.nih.gov/pubmed/30693028
http://dx.doi.org/10.1155/2019/3905817

Ejemplares similares